Skip to main content

Month: September 2020

Cartier présente les fortes capacités de hissage du puits de la propriété Mine Chimo

Faits saillants :Avec de simples adaptations, 1,7 millions de tonnes métriques par année (4 921 tm/jr) pourraient être extraites par le puits de la propriété Mine Chimo.Les résultats de cette étude s’inscrivent dans le cadre de 4 études d’ingénierie en cours ainsi que d’une étude préparatoire à la réalisation d’une nouvelle estimation des ressources de la propriété Mine Chimo afin d’en révéler sa pleine valeur.VAL-D’OR, Québec, 22 sept. 2020 (GLOBE NEWSWIRE) — Ressources Cartier Inc. (TSX-V: ECR) (“Cartier”) rapporte les résultats d’une étude d’ingénierie sur les capacités de hissage de l’infrastructure minière souterraine de la propriété Mine Chimo. Cette propriété, dont les intérêts sont détenus à 100% par Cartier, est située à 45 km à l’Est du camp minier de Val-d’Or.L’étude révèle que les composantes de la structure interne...

Continue reading

Brazil Approves RedHill Biopharma’s Phase 2/3 COVID-19 Study with Opaganib

The ongoing global Phase 2/3 study with orally-administered opaganib in patients with severe COVID-19 is approved in Italy, the UK, Russia, Israel, Mexico and Brazil; 16 clinical sites initiated globally to date—In parallel, the opaganib U.S. Phase 2 study, with 8 active clinical sites, is approximately 75% enrolled and expected to be completed in the coming weeks—Opaganib completely inhibited SARS-CoV-2 viral replication in an in vitro human lung cell model, comparing favorably with remdesivir, the positive control in the study—Opaganib demonstrated dual anti-inflammatory and antiviral activity and targets a host cell component, unaffected by viral mutation, thus minimizing the likelihood of resistance—Global emergency use authorization applications planned, subject to positive clinical resultsTEL AVIV, Israel...

Continue reading

PyroGenesis Unveils Strategy to Become Global On-Site Dross Processor Delivering Zero-Landfill/Reduced Carbon Solution; Reduces GHG Emissions; Provides General DROSRITE™ Update

MONTREAL, Sept. 22, 2020 (GLOBE NEWSWIRE) — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, unveils today, at its Annual and Special Meeting of Shareholders, a strategy to become a global on-site dross processor delivering zero-landfill/reduced carbon, and further underscored how DROSRITE™ reduces greenhouse gas (GHG) emissions.The Company is pleased to provide additional information with respect to this strategy as well as a general DROSRITE™ update in the following Q&A format.Q. Before we jump into the essence of your announcement, could you once...

Continue reading

“Grindeks” Group strategy has identified four development directions

“Grindeks” Group strategy has identified four development directions   JSC “Grindeks” informs of identifying four major strategy development directions of Group’s strategy until 2025:1) range increase of the active pharmaceutical ingredients and the final dosage forms;2) expansion in the new markets – European Union countries, US, Japan, South Korea, Australia and New Zealand;3) enlargement of the manufacturing infrastructure in Latvia;4) development of the subsidiary JSC “Kalceks”.JSC “Grindeks” strategy assumes the company to continue the focus on expanding the product range of cardiovascular, central nervous system, oncology and diabetes medications. It is expected, that in 2025 product range of mentioned therapeutic groups will consist of 105 final dosage form units, which will be exported to 97 countries around the world. To strengthen...

Continue reading

“Grindeks” koncerna stratēģija paredz četrus attīstības virzienus

“Grindeks” koncerna stratēģija paredz četrus attīstības virzienusAkciju sabiedrība “Grindeks” informē, ka ir izstrādājusi “Grindeks” koncerna attīstības stratēģiju līdz 2025. gadam, izvirzot šādus nozīmīgākos attīstības virzienus:1) jaunu aktīvo farmaceitisko vielu un gatavo zāļu formu klāsta paplašināšana;2) darbības paplašināšana jaunos tirgos – Eiropas Savienības valstīs, ASV, Japānā, Dienvidkorejā, Austrālijā un Jaunzēlandē;3) ražošanas infrastruktūras paplašināšana Latvijā;4) meitas uzņēmuma AS “Kalceks” attīstība.AS “Grindeks” stratēģija paredz, ka uzņēmums turpmāk fokusēsies uz sirds un asinsvadu, centrālo nervu sistēmu ietekmējošo, pretvēža un diabēta ārstēšanas medikamentu klāsta paplašināšanu. Plānots, ka 2025. gadā produktu klāstu šajās terapeitiskajās grupās veidos 105 gatavo zāļu formas, un tās tiks eksportētas uz 97 pasaules...

Continue reading

DTE Energy Company Announces Junior Subordinated Debentures Offering

Detroit, Sept. 22, 2020 (GLOBE NEWSWIRE) — DETROIT, Sept. 22, 2020 — DTE Energy Company (NYSE: DTE) announced today its intention to offer for sale, subject to market and other conditions, a new series of junior subordinated debentures due Oct. 15, 2080.DTE intends to use the net proceeds of the offering to redeem its 2012 Series C 5.250% junior subordinated debentures due 2062 of which $200 million aggregate principal amount are outstanding. This news release shall not constitute a notice of redemption of the 2012 Series C 5.250% junior subordinated debentures or an obligation to issue a notice of redemption.BofA Securities, Morgan Stanley, and Wells Fargo Securities will be joint book running managers for the offering.The offering will be made under an effective shelf registration statement, as amended, filed with the U.S. Securities...

Continue reading

Aequus Announces Expansion of Medicom Partnership and Filing with Health Canada for Additional Evolve Dry Eye Product

VANCOUVER, British Columbia, Sept. 22, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”), a specialty pharmaceutical company announced today that it has expanded its partnership with Medicom Healthcare (“Medicom”) to include an additional formulation in the Evolve® preservative free dry eye product line. Aequus has submitted an application for this new product with Health Canada for processing of a New Medical Device License (“MDL”).The new Evolve® product added to the existing Agreement is a unique preservative free formulation. The product formulation combines Hyaluronate and Carbomer 980 for the treatment of patients with more intense dry eye symptoms.With the addition of this product to the Health Canada submission, Aequus plans to launch a full range of products designed...

Continue reading

DTE Energy and Consumers Energy pledge to help build extensive Midwest electric vehicle charging network

DETROIT and JACKSON, Mich., Sept. 22, 2020 (GLOBE NEWSWIRE) — DTE Energy and Consumers Energy have announced they are joining a first-of-its-kind pledge to make interstate travel easier for electric vehicle (EV) owners by 2022. Six energy companies will join in facilitating the construction of a vast network of fast charging stations across the Midwest from Michigan to Kansas, making it possible for EV owners to drive longer distances without worrying about their next charge.Automotive industry watchers believe that the lack of convenient fast charging – given that the number of fast chargers is significantly less than the number of gas stations on the highways – has been a factor holding some vehicle shoppers back from purchasing EVs. DTE’s and Consumers’ pledge to assist in the creation of the Midwest charging network will help...

Continue reading

Welding Consumables Market to Hit USD 15.15 billion by 2027; Exciting Advancements in Welding Technologies to Brighten Market Prospects: Fortune Business Insights™

Pune, Sept. 22, 2020 (GLOBE NEWSWIRE) — The global welding consumables market size is projected to reach USD 15.15 billion by 2027, exhibiting a CAGR of 3.3% during the forecast period. Development of robotic welding systems is expected to propel the growth of this market in the near future, finds Fortune Business Insights™ in its report, titled “Welding Consumables Market Size, Share & COVID-19 Impact Analysis, By Type (Stick Electrodes, Solid Wires, Flux-corded Wires and SAW Wires & Fluxes), By Application (Heavy Engineering, Automotive, Railways, Construction, Shipbuilding and others) and Regional Forecast, 2020-2027”.Click here to get the short-term and long-term impact of COVID-19 on this market. Please visit: https://www.fortunebusinessinsights.com/enquiry/covid19-impact/welding-consumables-market-101598A few key...

Continue reading

E Split Corp. Completes Overnight Offering of $32.6 Million  

Not for distribution to U.S. Newswire Services or for dissemination in the United States.CALGARY, Alberta, Sept. 22, 2020 (GLOBE NEWSWIRE) — Middlefield Group, on behalf of E Split Corp. (TSX: ENS and ENS.PR.A) (the “Company”), is pleased to announce the Company has completed the overnight offering of class A and preferred shares (the “Class A Shares” and “Preferred Shares”, respectively) for aggregate gross proceeds of approximately $32.6 million. The Class A Shares and Preferred Shares will trade on the Toronto Stock Exchange under the existing symbols ENS (Class A Shares) and ENS.PR.A (Preferred Shares).The Class A Shares were offered at a price of $11.75 per Class A Share to yield 13.3% and the Preferred Shares were offered at a price of $10.00 per Preferred Share to yield 5.3%. The Class A Share and Preferred Share offering...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.